Barclays
CDIOW icon

Barclays’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Barclays’s Portfolio CDIOW Stock Details CDIOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-49,100
Closed -$8K – 4819
2022
Q2 		$8K Hold
49,100
– – ﹤0.01% 4683
2022
Q1 		$10K Buy
+49,100
New +$11.7K ﹤0.01% 4598

Other funds holding CDIOW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
FLC
Fifth Lane Capital Austin, Texas $82.3M AUM 26.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays's CDIOW Position: Q3 2022 in Review

Barclays sold out of Cardio Diagnostics Holdings Inc Warrant (CDIOW) in Q3 2022, closing a stake of 49,100 shares — an estimated $8K sold.

Barclays first reported a position in CDIOW in Q1 2022 and held it in 2 quarters. The position peaked at $10K in Q1 2022. 21 funds tracked by Wall St. Rank hold CDIOW as of Q3 2022.

  • Barclays reported no remaining Cardio Diagnostics Holdings Inc Warrant position as of Q3 2022 after selling out during the quarter.
  • Barclays sold 49,100 Cardio Diagnostics Holdings Inc Warrant shares in Q3 2022, an estimated $8K.
  • Barclays first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and held it in 2 quarters.
  • Barclays's Cardio Diagnostics Holdings Inc Warrant position peaked at $10K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.